Virtus ETF Advisers’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,720
Closed -$71.2K 525
2024
Q4
$71.2K Sell
6,720
-2,541
-27% -$26.9K 0.03% 362
2024
Q3
$122K Buy
9,261
+163
+2% +$2.15K 0.06% 350
2024
Q2
$89.4K Buy
9,098
+3,180
+54% +$31.3K 0.04% 364
2024
Q1
$81.4K Sell
5,918
-410
-6% -$5.64K 0.04% 391
2023
Q4
$108K Buy
+6,328
New +$108K 0.07% 333